EUVIMEDEUVIMED entdecken
Crossref

CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives

Kamal Prasad Regmi, Prakash Paudel, Hye-Soo Park, Min-Su Kim, So-Ra Han, Hwa-Jung Kim, Tae-Jin Oh

Catalysis Science & Technology · 2026

DOI: 10.1039/d6cy01228k ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catalysis Science & Technology, 2026. Verfasst von Kamal Prasad Regmi und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CYP109J6 exhibits an unusual reductive activity, selectively converting trifluoromethylated coumarins into 3,4-dihydrocoumarins. Experimental and computational analyses highlight a noncanonical catalytic function of bacterial cytochrome P450 enzymes.

Förderung

  • National Research Foundation

Zitieren

APA

Regmi, K. P., Paudel, P., Park, H., Kim, M., Han, S., Kim, H., & Oh, T. (2026). CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives. Catalysis Science & Technology. https://doi.org/10.1039/d6cy01228k

Vancouver

Regmi KP, Paudel P, Park H, Kim M, Han S, Kim H, et al. CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives. Catalysis Science & Technology. 2026. doi:10.1039/d6cy01228k

BibTeX
@article{Regmi2026,
  author = {Regmi, Kamal Prasad and Paudel, Prakash and Park, Hye-Soo and Kim, Min-Su and Han, So-Ra and Kim, Hwa-Jung and Oh, Tae-Jin},
  title = {CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives},
  journal = {Catalysis Science & Technology},
  year = {2026},
  doi = {10.1039/d6cy01228k}
}
Kostenlos starten →